Darmstadt, Germany (ots/PRNewswire) - - Development and commercialization agreement on blood-based RAS biomarker mutation status test for (metastatic) colorectal cancer (mCRC) - This non-invasive, fast and easy-to-perform diagnostic test is expected to provide a real-time reflection of a patient's RAS mutation status to help guide clinical decision making in mCRC Merck ...
Darmstadt, Germany (ots/PRNewswire) - ASCO abstract #: Anti-PD-L1: 3064; c-Met: 2521, TPS4151, TPS8121; tecemotide: TPS3658, TPS7608; TH-302: 8534, 2029; further pipeline: 3551, TPS9107, 5030, 2050, e13552 - Robust pipeline reflects commitment to innovation in oncology and immuno-oncology - Data from nine Merck ...
Darmstadt, Germany (ots/PRNewswire) - - For the 6th time in a row Merck Serono takes part in the International Thyroid Awareness Week with focus on HIGH FIVE - Five reasons to be aware of thyroid disease: Thyroid cancer, autoimmunity, infertility, anxiety/depression, and iodine deficiency Merck Serono, the biopharmaceutical division of Merck, together with Thyroid ...
Darmstadt, Germany (ots/PRNewswire) - ASCO Abstract Number: 3506 - In a retrospective analysis of the Phase III CRYSTAL* study, which assessed RAS tumor status, significant clinical benefit was observed in mCRC patients with RAS wild-type tumors receiving Erbitux plus FOLFIRI, compared with FOLFIRI alone - No ...
Darmstadt, Germany (ots/PRNewswire) - - Primary endpoint met in SPARK study: significant increase in phenylalanine tolerance demonstrated after 26 weeks of the study in children less than 4 years of age with phenylketonuria and responsive to Kuvan treated with Kuvan plus a phenylalanine-restricted diet, versus diet alone - SPARK study was conducted as a post-authorization measure and results will be submitted to EMA this ...
Darmstadt, Germany (ots/PRNewswire) - - First patient dosed in tecemotide Phase III trial; study recruiting across 250 sites in over 20 countries - START2 builds upon the data from the START* trial and explores the potential of tecemotide in patients with Stage III NSCLC who have demonstrated stable disease or ...
Darmstadt, Germany (ots/PRNewswire) - - The multidisciplinary Oncology Partnership and Education Network (OPEN) aims to improve patient outcomes in oncology, with initial focus on metastatic colorectal cancer (mCRC) - OPEN aims to raise public awareness and understanding of the importance of biomarker testing in mCRC Merck Serono, the biopharmaceutical division of ...
Darmstadt, Germany (ots/PRNewswire) - - The ESPART* Phase III clinical study focuses on patients that respond poorly to attempts at ovarian stimulation - Study aims to recruit 946 patients across 17 European countries Merck, the global pharmaceutical and chemical company, today announced the enrollment of the first ...
Darmstadt, Germany (ots/PRNewswire) - - The European Commission's approval is based on the CHMP positive opinion - Label update comes in response to new biomarker data obtained from the OPUS study Merck Serono, the biopharmaceutical division of Merck, today announced that the European Commission has approved the ...
Darmstadt, Germany (ots/PRNewswire) - - New agreement aims to translate CNIO research into new potential treatment options for cancer patients - License agreement encompasses two series of ATR inhibitors and a screening platform Merck Serono, the biopharmaceutical division of Merck, today announced that a license ...
Darmstadt, Germany (ots/PRNewswire) - - Publication offers detailed results of START, including an exploratory analysis of the clinically meaningful survival prolongation with tecemotide maintenance therapy in a predefined subgroup of patients treated with concurrent chemoradiotherapy - As previously announced Merck ...
Darmstadt, Germany (ots/PRNewswire) - - CHMP recommendation comes in response to new biomarker data obtained from the OPUS study Merck Serono, the biopharmaceutical division of Merck, today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a ...
Darmstadt, Germany (ots/PRNewswire) - - New agreement marks the second collaboration between Merck and BeiGene Merck Serono, the biopharmaceutical division of Merck, today announced that a global licensing, co-development, and commercialization agreement for BeiGene-290 has been signed with BeiGene Co., Ltd., a ...
company: Software AG Uhlandstr. 12 D-64297 Darmstadt phone: +49 (0)6151 92 1899 FAX: +49 (0) 6151 92 1933 mail: investor.relations@softwareag.com WWW: http://www.softwareag.com sector: Software ISIN: DE0003304002 indexes: TecDAX, CDAX, HDAX, Prime All Share, Technology All Share stockmarkets: free trade: Hannover, Berlin, Hamburg, Düsseldorf, Stuttgart, regulated dealing/prime standard: Frankfurt language: English ...
issuer: Software AG Uhlandstr. 12 D-64297 Darmstadt phone: +49 (0)6151 92 1899 FAX: +49 (0) 6151 92 1933 mail: investor.relations@softwareag.com WWW: http://www.softwareag.com sector: Software ISIN: DE0003304002 indexes: TecDAX, CDAX, HDAX, Prime All Share, Technology All Share stockmarkets: free trade: Hannover, Berlin, Hamburg, Düsseldorf, Stuttgart, regulated dealing/prime standard: Frankfurt language: English ...
issuer: Software AG Uhlandstr. 12 D-64297 Darmstadt phone: +49 (0)6151 92 1899 FAX: +49 (0) 6151 92 1933 mail: investor.relations@softwareag.com WWW: http://www.softwareag.com sector: Software ISIN: DE0003304002 indexes: TecDAX, CDAX, HDAX, Prime All Share, Technology All Share stockmarkets: free trade: Hannover, ...
company: Software AG Uhlandstr. 12 D-64297 Darmstadt phone: +49 (0)6151 92 1899 FAX: +49 (0) 6151 92 1933 mail: investor.relations@softwareag.com WWW: http://www.softwareag.com sector: Software ISIN: DE0003304002 indexes: TecDAX, CDAX, HDAX, Prime All Share, Technology All Share stockmarkets: free trade: Hannover, Berlin, Hamburg, Düsseldorf, Stuttgart, regulated ...
company: Software AG Uhlandstr. 12 D-64297 Darmstadt phone: +49 (0)6151 92 1899 FAX: +49 (0) 6151 92 1933 mail: investor.relations@softwareag.com WWW: http://www.softwareag.com sector: Software ISIN: DE0003304002 indexes: TecDAX, CDAX, HDAX, Prime All Share, Technology All Share stockmarkets: free trade: Hannover, Berlin, Hamburg, Düsseldorf, Stuttgart, regulated dealing/prime standard: Frankfurt language: English ...
issuer: Software AG Uhlandstr. 12 D-64297 Darmstadt phone: +49 (0)6151 92 1899 FAX: +49 (0) 6151 92 1933 mail: investor.relations@softwareag.com WWW: http://www.softwareag.com sector: Software ISIN: DE0003304002 indexes: TecDAX, CDAX, HDAX, Prime All Share, Technology All Share stockmarkets: regulated ...
issuer: Software AG Uhlandstr. 12 D-64297 Darmstadt phone: +49 (0)6151 92 1899 FAX: +49 (0) 6151 92 1933 mail: investor.relations@softwareag.com WWW: http://www.softwareag.com sector: Software ISIN: DE0003304002 indexes: TecDAX, CDAX, HDAX, Prime All Share, Technology All Share stockmarkets: regulated ...